ROYAL BANK OF CANADA - SUMMIT THERAPEUTICS INC ownership

SUMMIT THERAPEUTICS INC's ticker is SMMT and the CUSIP is 86627T108. A total of 56 filers reported holding SUMMIT THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.26 and the average weighting 0.0%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of SUMMIT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$36,000
+20.0%
19,479
+60.3%
0.00%
Q2 2023$30,000
+2900.0%
12,148
+1846.8%
0.00%
Q1 2023$1,000
-90.9%
624
-75.9%
0.00%
Q4 2022$11,000
+175.0%
2,593
+60.1%
0.00%
Q1 2022$4,000
-73.3%
1,620
-72.3%
0.00%
Q4 2021$15,000
-11.8%
5,846
+76.6%
0.00%
Q3 2021$17,000
+54.5%
3,310
+115.1%
0.00%
Q2 2021$11,0001,539
+7228.6%
0.00%
Q1 2021$0210.00%
Other shareholders
SUMMIT THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Alpine Global Management, LLC 202,928$8620.29%
AWM Investment Company, Inc. 300,000$1,275,0000.18%
Virtus ETF Advisers LLC 42,835$182,0490.10%
Baker Brothers Advisors 2,000,000$8,500,0000.05%
VANCE WEALTH, INC. 13,299$56,5210.04%
Inscription Capital, LLC 17,000$72,2500.02%
Steward Partners Investment Advisory, LLC 305,000$1,296,2500.02%
BOOTHBAY FUND MANAGEMENT, LLC 221,205$940,1210.02%
LEVIN CAPITAL STRATEGIES, L.P. 39,176$166,4980.02%
683 Capital Management, LLC 50,838$216,0620.02%
View complete list of SUMMIT THERAPEUTICS INC shareholders